Fierce 15 Hero
Special Reports

Fierce Biotech's 2025 Fierce 15

From advancing radically new therapies to refining existing modalities, this year’s Fierce 15 companies are pushing the envelope and giving us a reason for optimism.
Gabrielle Masson Sep 22, 2025 8:00am
Getting to Yes How Deal-Making Fuels Biotech Growth

Getting to Yes: How Deal-Making Fuels Biotech Growth

Sep 17, 2025 3:20pm
Car reaches the end of the road

Rome nears end of road with planned layoffs, strategic review

Sep 23, 2025 2:00pm
new york stock exchange

New York Stock Exchange honors Fierce 15 winners

Sep 23, 2025 10:16am
weight loss drugs obesity

Roche's obesity ambition not reliant on one megablockbuster

Sep 23, 2025 7:45am
step up climb ladder sky hang on rung

BMS reports phase 3 win in multiple myeloma

Sep 23, 2025 8:20am
More News

Fierce Biotech Layoff Tracker 2025: Rome, Seres & more

Sep 23, 2025 2:45pm

Seres shrinks head count by 25% to fund biotherapeutic's ph. 2

Sep 23, 2025 10:00am

Glooko buys Monarch’s EndoTool to enter in-patient diabetes care

Sep 23, 2025 7:30am

Merck inks $349M biobucks deal to apply AI to tricky targets

Sep 23, 2025 7:00am